Jane Street Group, LLC Merrimack Pharmaceuticals Inc Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$13.06 - $15.0 $145,279 - $166,860
11,124 New
11,124 $164,000
Q1 2023

May 15, 2023
BUY
$11.35 - $12.32 $423,434 - $459,622
37,307 New
37,307 $458,000
Q1 2018

May 15, 2018
SELL
$6.24 - $9.15 $65,195 - $95,599
-10,448 Closed
0 $0
Q4 2017

Feb 15, 2018
BUY
$7.99 - $11.87 $83,479 - $124,017
10,448
10,448 $107,000

Others Institutions Holding MACK

# of Institutions
1
Shares Held
77
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email